Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Creative Medical Technology Holdings Inc (NQ: CELZ ) 3.510 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Creative Medical Technology Holdings Inc Creative Medical Technology Holdings Provides Corporate Update March 27, 2024 From Creative Medical Technology Holdings, Inc. Via Business Wire Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA March 08, 2024 Via AB Newswire Exposures Product Safety Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access March 07, 2024 From Creative Medical Technology Holdings, Inc. Via Business Wire Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy March 06, 2024 From Creative Medical Technology Holdings, Inc. Via Business Wire What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth? August 24, 2023 Via ACCESSWIRE Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain December 20, 2023 Via ACCESSWIRE Creative Medical Technology Reports Advancements In Regenerative Medicine And Improvements In Financial Position In Corporate Update July 13, 2023 Via ACCESSWIRE Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201 March 07, 2023 From Creative Medical Technology Holdings, Inc. Via Business Wire Three Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects February 14, 2023 From Creative Medical Technology Holdings, Inc. Via Business Wire InvestorNewsBreaks – Creative Medical Technology (NASDAQ: CELZ) Expects $17 Million Gross Proceeds from Private Placement May 16, 2022 Via Investor Brand Network Optimism Builds for Promising Developments & New Drug Therapies Targeting Treatments for Breast Cancer March 24, 2022 Palm Beach, FL – March 24, 2022 – FinancialNewsMedia.com News Commentary – The status of breast cancer as one of the most commonly occurring cancers in the world is expected to be a key driving factor... Via FinancialNewsMedia Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
